MarketInOut Stock Screener Log In | Sign Up
 

Repligen Corp

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 09/16/2026 16:00
Repligen Corp stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,861 mln
Float56.27 mln
Earnings Date11/03/2026

EPS

0.75
Stretched

P / E

231
Bubble territory

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.74
Likely reliable

1-Year Forecast

188
Modest upside

Relative Strength

84 / 100
Strongly outperforming

Business Description

Repligen is a Massachusetts-based company founded in 1981 that makes tools and equipment used in the production of biological medicines. Its products help drug manufacturers filter, purify, monitor, and refine biological compounds throughout the manufacturing process. The company sells to pharmaceutical firms, research laboratories, and contract manufacturers across North America, Europe, Asia, and other regions worldwide.

Key Fundamentals

EPS0.75
P/E231
ROE1.98
RPS13.94
ROIC2.46
ROA1.42
Interest Cover2.95
EBITDA, mln172
EV / EBITDA57.26
EV / EBIT132
Revenue, mln785
EV / Revenue12.52

Financial Strength

Altman Z-Score8.13
Piotroski F-Score 8 / 9
Beneish M-Score-2.74
Price to Intrinsic Value4.04
Price to Graham Number7.80
1-Year Target Price188
Shiller PE Ratio156
Short Ratio6.73
Short % of Float11.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.76% 93 / 100   
1 Month 2.29% 84 / 100   
2 Months 32.87% 94 / 100   
6 Months 44.97% 92 / 100   
1 Year 52.02% 90 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us